Location History:
- Stevenage Herts, GB (2006)
- Waltham, MA (US) (2001 - 2009)
Company Filing History:
Years Active: 2001-2009
Title: **The Innovative Contributions of David P. Andrew**
Introduction
David P. Andrew, a notable inventor based in Waltham, MA, has made significant strides in the field of biomedical science. With a portfolio of eight patents, he has contributed valuable inventions that advance the treatment of inflammatory diseases.
Latest Patents
Among his latest patents is a groundbreaking invention focused on methods of treating inflammatory diseases using antibodies that bind to GPR-9-6. This invention details an antibody or antigen-binding fragment that binds to the CC chemokine receptor GPR-9-6, effectively blocking the binding of the ligand TECK to the receptor. Additionally, it provides methods for identifying agents that can bind to GPR-9-6 and inhibit ligand binding or modulate the receptor's function. This invention further outlines applications of the antibodies and identified agents in research, therapeutic, prophylactic, and diagnostic methods.
Another notable patent by David involves anti-TECK antibodies and their uses. This invention pertains to antibodies or antigen-binding fragments that bind to the chemokine mammalian TECK, inhibiting its interaction with mammalian GPR-9-6. It also encompasses host cells that produce such antibodies, along with kits and methods of use for these antibodies and fragments.
Career Highlights
David P. Andrew is currently associated with Millennium Pharmaceuticals Limited, where he continues to innovate in the biopharmaceutical sector. His work emphasizes the development of novel treatments that target specific receptors involved in inflammatory diseases, which is crucial for improving patient outcomes.
Collaborations
Throughout his career, David has collaborated with esteemed colleagues such as Paul D. Ponath and Brian A. Zabel. These partnerships have enabled him to delve deeper into complex biological mechanisms and enhance the scope and impact of his inventions.
Conclusion
David P. Andrew exemplifies the essence of innovation in the realm of biomedical research. His contributions through patents not only reflect his expertise as an inventor but also hold promise for developing new therapeutic approaches to treat inflammatory diseases. As he continues his work at Millennium Pharmaceuticals Limited, his ongoing research will undoubtedly pave the way for future advancements in healthcare.